China Veterinary Healthcare Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Market is Segmented on the basis of Product (Therapeutics and Diagnostics), and Animal Type

Market Snapshot

China Animal Healthcare Market Overview
Study Period: 2018 - 2026
Base Year: 2020
CAGR: 6 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The China veterinary healthcare Market studied was anticipated to grow with a CAGR of nearly 6% during the forecast period. The risk from zoonotic diseases and the growing consumption of meat, pork, and beef are the major factors fuelling the growth of the Chinese veterinary healthcare market. Inter-governmental organizations and food production agencies are making reforms to ensure proper health, by the process of surveillance and vaccination and by investing in R&D. CAHG is one of the two subsidiaries of China National Agricultural Development Group Corporation (CNADGC), under the governance of the State-owned Assets Supervision and Administration Commission of the State Council (SASAC), the People’s Republic of China (PRC). Additionally, advanced technology, leading to innovations in animal healthcare, is also a factor that is responsible for the growth of the Chinese veterinary healthcare market. However, the growing trend of counterfeit prescription pharmaceuticals and the lack of skilled veterinarians are a few factors that are hampering the growth of the Chinese veterinary healthcare market.

Scope of the Report

As per the scope of this report, the Chinese veterinary healthcare market comprises therapeutic and diagnostic products and solutions for companion and farm animals. Companion animals can be tamed or adopted for companionship or as house/office guards, and farm animals are raised for meat and milk-related products. Companion animals include canines, felines, and equines. Farm animals include bovine, poultry, and porcine.

By Product
By Therapeutics
Vaccines
Parasiticides
Anti-infectives
Medical Feed Additives
Other Therapeutics
By Diagnostics
Immunodiagnostic Tests
Molecular Diagnostics
Diagnostic Imaging
Clinical Chemistry
Other Diagnostics
By Animal Type
Dogs and Cats
Horses
Ruminants
Swine
Poultry
Other Animals

Report scope can be customized per your requirements. Click here.

Key Market Trends

The Dogs and Cats Segment Dominates the China Veterinary Healthcare Market

  • The Chinese veterinary health products for dogs and cats are gaining positive recognition across the industry. The increased adoption of dogs and cats in China is the major driving factor for the market.
  • There has also been an increased awareness about animal vaccinations and the overall health of dogs and cats, in recent years, in China. In 2017, in China, more than 3,500 cats and dogs were rescued from various diseases, primarily through animal welfare programs, funded by the Animals Asia Foundation. The animals were rescued and vaccinated efficiently. Thus, these organizations are focusing on protecting the animals’ health as well as saving their lives.
  • Furthermore, company expansions, the launch of new products are projected to propel the market growth over the forecast period. For instance, in 2018, Zoetis expanded animal vaccine R&D in China to target the prevalent diseases in the country. The company is expecting that such vaccines will ultimately become a vital health management tool within this industry.
china pet

NA

NA

NA

Competitive Landscape

The China veterinary healthcare market is highly competitive. Over the recent years, multinational pharmaceutical enterprises began to realize that China provides great opportunities in the animal health sector, where the emergence of new diseases among pigs, new government policies to improve food safety, and the overall development of the pig industry point toward the future growth of the country's veterinary healthcare market. For instance, in January 2019, Boehringer Ingelheim launched its swine vaccine, Ingelvac PRRS MLV, produced by its veterinary vaccine manufacturing plant, in China Medical City in Taizhou, Jiangsu Province. This vaccine is now officially supplied to the Chinese markets.

The key market players operating in china veterinary healthcare market are MSD Animal Health, Vetoquinol SA, Bayer AG, Boehringer Ingelheim and Elanco among others.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increase in Pet Adoption

      2. 4.2.2 Advanced Technology in Animal Healthcare

      3. 4.2.3 Rise in the number of Initiatives by Governments and Animal Welfare Associations

    3. 4.3 Market Restraints

      1. 4.3.1 Use of Counterfeit Medicines

      2. 4.3.2 Increasing Costs of Animal Testing and Veterinary Care

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product

      1. 5.1.1 By Therapeutics

        1. 5.1.1.1 Vaccines

        2. 5.1.1.2 Parasiticides

        3. 5.1.1.3 Anti-infectives

        4. 5.1.1.4 Medical Feed Additives

        5. 5.1.1.5 Other Therapeutics

      2. 5.1.2 By Diagnostics

        1. 5.1.2.1 Immunodiagnostic Tests

        2. 5.1.2.2 Molecular Diagnostics

        3. 5.1.2.3 Diagnostic Imaging

        4. 5.1.2.4 Clinical Chemistry

        5. 5.1.2.5 Other Diagnostics

    2. 5.2 By Animal Type

      1. 5.2.1 Dogs and Cats

      2. 5.2.2 Horses

      3. 5.2.3 Ruminants

      4. 5.2.4 Swine

      5. 5.2.5 Poultry

      6. 5.2.6 Other Animals

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Bayer AG

      2. 6.1.2 Boehringer Ingelheim

      3. 6.1.3 Elanco

      4. 6.1.4 Merck & Co., Inc.

      5. 6.1.5 Vetoquinol SA

      6. 6.1.6 Virbac Corporation

      7. 6.1.7 Zoetis Inc

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The China Veterinary Healthcare Market market is studied from 2018 - 2026.

The China Veterinary Healthcare Market is growing at a CAGR of 6% over the next 5 years.

Vetoquinol SA, Bayer AG, Boehringer Ingelheim, Elanco, Merck & Co., Inc. are the major companies operating in China Veterinary Healthcare Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!